Table Of ContentCover
Page i
SIROLIMUSELUTING STENTS
FROM RESEARCH TO CLINICAL PRACTICE
Page ii
Other Taylor & Francis Titles byPatrick W Serruys
Handbook of Coronary Stents (1997, 1998, 2000, 2002)
Frontiers in Interventional Cardiology (1997)
Handbook of Vascular Brachytherapy (1998, 2000)
Coronary Stenting: Current Perspectives, a Companion to the Handbook of Coronary Stents (1999)
Coronary Lesions: A Pragmatic Approach (2001)
High Risk Cardiac Revascularization (2002)
Handbook of the Vulnerable Plaque (2004)
Handbook of Cardiac Cell Transplantation (2004)
Handbook of Drug Eluting Stents (2005)
Page iii
SIROLIMUS ELUTING STENTS
FROM RESEARCH TO CLINICAL PRACTICE
Edited by
Patrick W Serruys MD PhD FACC FESC
Professor and Head
Department of Interventional Cardiology
Thoraxcenter
Erasmus University
Rotterdam
The Netherlands
and
Pedro A Lemos MD PhD
Interventional Cardiologist
Interventional Cardiology Service
Heart Institute (InCor)
University of São Paulo Medical School
São Paulo
Brazil
Foreword by
Martin B Leon MD
Chairman, Cardiovascular Research Foundation
Columbia University School of Medicine
New York NY
USA
LONDON AND NEW YORK
A MARTIN DUNITZ BOOK
Page iv
© 2005 Taylor & Francis, an imprint of the Taylor & Francis Group
First published in the United Kingdom in 2004
by Taylor & Francis, an imprint of the Taylor & Francis Group,
2 Park Square, Milton Park, Abingdon, Oxon, OX14 4RN
Tel.: +44 (0)1235 828600
Fax.: +44 (0)1235 829000
Email: [email protected]
Website: http://www.dunitz.co.uk
This edition published in the Taylor & Francis eLibrary, 2005.
To purchase your own copy of this or any of Taylor & Francis or Routledge’s collection of thousands of eBooks please go to www.eBookstore.tandf.co.uk.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system,
or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording,
or otherwise, without the prior permission of the publisher or in accordance with the provisions
of the Copyright, Designs and Patents Act 1988 or under the terms of any licence permitting
limited copying issued by the Copyright Licensing Agency, 90 Tottenham Court Road, London
W1P 0LP.
Although every effort has been made to ensure that all owners of copyright material have been
acknowledged in this publication, we would be glad to acknowledge in subsequent reprints or
editions any omissions brought to our attention.
A CIP record for this book is available from the British Library.
Library of Congress CataloginginPublication Data
Data available on application
ISBN 0203306872 Master ebook ISBN
ISBN (OEB Format)
ISBN 1 84184 492 6 (Print Edition)
Distributed in North and South America by
Taylor & Francis
2000 NW Corporate Blvd
Boca Raton, FL 33431, USA
Within Continental USA
Tel.: 800 272 7737; Fax.: 800 374 3401
Outside Continental USA
Tel.: 561 994 0555; Fax.: 561 361 6018
Email: [email protected]
Distributed in the rest of the world by
Thomson Publishing Services
Cheriton House
North Way
Andover, Hampshire SP10 5BE, UK
Tel.: +44 (0)1264 332424
Email: [email protected]
Composition by Scribe Design, Ashford, Kent, UK
Page v
To all the international fellows who have worked in the Thoraxcenter in the past (1976–2004) and I thank them for having made me wiser….
PWS
To my wife, Francine
PAL
Page vi
CONTENTS
Contributors ix
Foreword xii
I SirolimusEluting Stents in the Clinical Practice: Concepts, and General Overview
1 SirolimusEluting Stents as an AntiRestenosis Device: Basic Concepts and Summary of Pivotal Studies 3
Patrick W Serruys, Pedro A Lemos
2 SirolimusEluting Stents in The ‘Real World’: The RESEARCH Registry Rationale and Study Design 15
Pedro A Lemos, Patrick W Serruys, Ron T van Domburg
3 Unrestricted Utilization of SirolimusEluting Stents for De Novo Coronary Lesions 23
Pedro A Lemos, Patrick W Serruys, Ron T van Domburg
II SirolimusEluting Stents for Patients at High Clinical Risk
4 Early Safety of SirolimusEluting Stents for Patients with Acute Coronary Syndromes 35
Pedro A Lemos, Chihang Lee, Patrick W Serruys
5 SirolimusEluting Stents for Patients with Acute Myocardial Infarction 41
Francesco Saia, Pedro A Lemos, Patrick W Serruys
6 SirolimusEluting Stents for Patients with Impaired Renal Function 49
Pedro A Lemos, Ron T van Domburg, Patrick W Serruys
7 Sirolimuseluting Stents for Patients with Prior Coronary Bypass Graft Surgery 53
Angela Hoye, Patrick W Serruys
8 SirolimusEluting Stents for Left Main Coronary Artery Disease 59
Chourmouzios A Arampatzis, Patrick W Serruys
9 SirolimusEluting Stents for Patients with Multivessel Coronary Disease 67
Chourmouzios A Arampatzis, Pedro A Lemos
Page vii
10 SirolimusEluting Stents for Elderlies 73
Maniyal Vijayakumar, Pedro A Lemos, Patrick W Serruys
III SirolimusEluting Stents for Patients at Special Anatomic Groups
11 SirolimusEluting Stents for Chronic Total Occlusions 79
Angela Hoye, Kengo Tanabe, Patrick W Serruys
12 SirolimusEluting Stents for Very Small Coronary Vessels 87
Pedro A Lemos, Patrick W Serruys
13 SirolimusEluting Stents for Very Long Lesions 93
Muzaffer Degertekin, Chourmouzios A Arampatzis, Pedro A Lemos
14 SirolimusEluting Stents for Bifurcation Lesions 99
Kengo Tanabe, Angela Hoye, Patrick W Serruys
15 SirolimusEluting Stents for Coronary Narrowings <50% in Diameter 107
Angela Hoye, Pedro A Lemos, Patrick W Serruys
16 SirolimusEluting Stents for InStent Restenosis 113
Francesco Saia, Patrick W Serruys
17 PostDilatation of Undersized SirolimusEluting Stents 125
Francesco Saia, Pedro A Lemos
IV Complications after SirolimusEluting Stents
18 Thrombotic Stent Occlusion After SirolimusEluting Stent Implantation 135
Evelyn Regar, Pedro A Lemos, Patrick W Serruys
19 Morphology and Mechanisms of Restenosis After SirolimusEluting Stents 141
Pedro A Lemos, Francesco Saia
20 Predictors of Restenosis after SirolimusEluting Stent Implantation in Complex Patients 147
Pedro A Lemos, Dick Goedhart, Patrick W Serruys
21 Late Luminal Loss Response Pattern after SirolimusEluting Stent Implantation or Conventional Stenting 153
Pedro A Lemos, Ron T Van Domburg, Patrick W Serruys
22 Treatment of PostSirolimusEluting Stent Restenosis 157
Pedro A Lemos, Carlos AG van Mieghem, Patrick W Serruys
Page viii
V Costs of SirolimusEluting Stents
23 CostEffectiveness of SirolimusEluting Stents 165
Patrick W Serruys, Ben van Hout, Pedro A Lemos
References 169
Index 189
Page ix
CONTRIBUTORS
Jiro Aoki MD
Research fellow
Catheterization Laboratory
Erasmus University Rotterdam
Erasmus Medical Center
Thoraxcenter
Rotterdam, The Netherlands
Chourmouzios A Arampatzis MD, PhD
Interventional Cardiologist
Euromedica Clinic
Thessaloniki, Greece
Marcel JBM van den Brand MD, PhD
Interventional Cardiologist
Catheterization Laboratory
Erasmus University Rotterdam
Erasmus Medical Center
Thoraxcenter
Rotterdam, The Netherlands
Paul Cummins RN
Research coordinator
Catheterization Laboratory
Erasmus University Rotterdam
Erasmus Medical Center
Thoraxcenter
Rotterdam, The Netherlands
Joost Daemen
Medical student
Erasmus University Rotterdam
Erasmus Medical Center
Rotterdam, Netherlands
Muzaffer Degertekin MD, PhD
Associate Professor of Cardiology
Department of Interventional Cardiology
Kosuyolu Heart & Research Hospital
Istanbul, Turkey
Ron T van Domburg PhD
Clinical Epidemiologist
Clinical Epidemiology Group
Erasmus University Rotterdam
Erasmus Medical Center
Thoraxcenter
Rotterdam, The Netherlands
Marco van Duuren
Medical student
Erasmus University Rotterdam
Erasmus Medical Center
Rotterdam, Netherlands
GerritAnne van Es PhD
Director of Research & Development
Cardialysis B.V.
Rotterdam, The Netherlands
Pim de J Feyter MD, PhD
Professor, NonInvasive Diagnosis of
Ischemic Heart Diseases
Interventional Cardiologist
Erasmus University Rotterdam
Erasmus Medical Center
Thoraxcenter
Rotterdam, The Netherlands
Willem J van der Giessen MD, PhD
Interventional Cardiologist
Catheterization Laboratory
Erasmus University Rotterdam
Erasmus Medical Center
Thoraxcenter
Rotterdam, The Netherlands
Dick Goedhart
Statistician
Cardialysis B.V.
Rotterdam, The Netherlands